Backgrounds/Aims: Surveillance programs and imaging modality developments have increased the detection rate of small hepatocellular carcinoma (HCC). In particular, liver transplantation produces good results and is now regarded an alternative to liver resection. However, optimal treatment for small HCC is still debated, and thus, the authors designed this study to document clinicopathological characteristics, to identify the prognostic factors of small HCC, and to determine the effectiveness of surgery. Methods: A total of 507 patients underwent curative liver resection for HCC between January 1996 and August 2006 in our institution. One hundred and thirty four of these patients with a single HCC of less than 3 cm and no gross vascular invasion were enrolled. Results: Major resection was performed in 32 (23.9%) patients; there was no postoperative mortality. Fifty-eight (43.3%) patients experienced recurrence, 53 developed intrahepatic recurrence alone, and 50 (94.3%) of 53 had tumors within the Milan criteria. Five-year disease-free and overall survival rates were 51.0% and 77.3%, respectively. Microscopic vascular invasion, positivity for hepatitis B surface antigen or antibody to hepatitis C, and an indocyanine green retention test at 15 minutes of more than 10% were found to be significantly correlated with disease-free overall survival. A platelet count of less than 100,000/mm 3 was the only independent prognostic factors of overall survival identified. Conclusions: This study showed favorable outcome comparable to the survival after liver transplantation, thus that liver resection appears to be the primary treatment option for small HCC, even in cases with poor prognostic factors. 
INTRODUCTION
The majority of hepatocellular carcinomas (HCC) arise in the background of chronic hepatitis and cirrhosis, and thus, liver transplantation is the most ideal treatment modality as it corrects the underling liver disease. However, because of the donor shortage situation, liver resection is the preferred treatment. Furthermore, the use of liver resection in patients with HCC is largely limited by advanced disease and poor liver function. Recently, a randomized controlled study was performed to determine the merits of HCC screening in China. 1 It was found screening confers survival benefits and that development of imaging modalities and surveillance programs have increased the detection rate of small resectable HCC. 2, 3 Several studies have reported the outcomes of treatment modalities for small HCC, [4] [5] [6] [7] [8] and despite the different definitions used for small HCC, liver transplantation has been proposed as an alternative strategy for small HCC instead of liver resection. 8, 9 Nevertheless, the optimal treatment for small HCC remains controversial. 10, 11 Small HCC has a favorable prognosis, but its outcome was different according to the prognostic stratification and prognostic scoring system for patients treated by liver resection. 6, 12 In the present study, we investigated the clinicopathological characteristics and prognostic factors of small HCC and attempted to determine the effectiveness of surgery with the intention of finding the best approach for its treatment. 
METHODS

Definitions
Statistical analysis
Statistical analysis was performed using SPSS v 12.0 software (SPSS Inc., Chicago, IL, USA). Continuous results are presented as medians (ranges) and categorical results are presented as numbers (percentages). Disease-free and overall survival rates were calculated using the Kaplan-Meier method. Prognostic factors of disease-free and overall survival rates were indentified using the log-rank test and univariate analysis. Multivariate analysis was performed using the Cox proportional hazard model; factors significant by univariate analysis were included. Statistical significance was accepted for p-values of ＜0.05.
RESULTS
Clinical characteristics
The clinical characteristics are presented in Table 1 .
The 134 study subjects had a median age of 53.1 years Table 2 ).
The 1-year, 3-year, and 5-year disease-free and overall survival rates were 82.0%, 62.4%, and 51.0%, and 97.0%, 89.5%, and 77.3%, respectively (Fig. 1) . for early HCC in Child-Pugh class B or C cirrhosis.
However, liver resection has also produced good results in patients with small HCC; in fact, the 5-year overall survival rate in the present study was 77.3%. These results
show, although the disease-free survival rate for liver resection is poorer than of liver transplantation, that the overall survival rates of liver resection and liver transplantation are similar for patients with small HCC, and suggest that liver resection is a good treatment option in patients with small HCC.
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The merits and demerits of major versus minor resection and anatomical resection versus non-anatomical resection are still debated for small HCC. In the present study, 102 (76.1%) patients underwent minor resection, including non-anatomical resection (n=20, 14.9%), and operation type was not found to be associated with disease-free or overall survival. In a previous report, we reported that non-anatomical resection for small HCC had no adverse effect on disease-free survival, 20 and other authors have reported similarly. 21, 22 In fact, these authors also concluded that minor and non-anatomical resection of small HCC (except for deep-seated HCCs or HCCs located alongside a major vessel) is an effective treatment option. Prognosis after HCC resection has been shown to be affected by tumor invasiveness and underlying liver function. [23] [24] [25] According to our results, the long-term prognosis of patients with a single small HCC is more associated with underlying liver function than invasiveness.
Microscopic vascular invasion and positivity for hepatitis B surface antigen may develop intrahepatic metastasis and de novo carcinogenesis, respectively, after resection, but in the present study, the majority of recurrences (n=53, 91.4%) were confined to the remaining liver. In addition, 50 patients developed nodular recurrence, which was well controlled by multimodality treatments and had a better prognosis than other recurrence patterns. These observations suggest that long-term prognosis is associated with liver function and the extent to which the liver can resist recurrence given aggressive treatment. However, according to our data, overall survival rate at 5 years after resection decreased, indicating that liver transplantation was eventually required because of the progression of underlying liver disease or HCC recurrence. Salvage liver transplantation provides an alternative in patients with recurrence after liver resection. However, the initial experiences with salvage liver transplantation were relatively poor, in which operative mortality was high (23.5%) and survival was unfavorable, but many of the of patients had a tumor beyond the Milan criteria. 26 It has been reported that salvage liver transplantation is feasible in 75-80% of patients after liver resection, 27 and in the present study, salvage liver transplantation was found to be feasible in 50 of 53 patients (94.3%). It was recently reported that salvage liver transplantation can be performed with acceptable morbidity and mortality rates and produce results comparable to those of primary liver transplantation. 28, 29 Furthermore, in one these previous studies, patients that underwent liver resection or liver transplantation showed similar survival rates by intention-to-treat analysis. 29 However, salvage rates of only up to 20% have been reported by others. [29] [30] [31] Thus, further studies are needed before salvage liver transplantation can be generally adopted.
Liver resection has been adopted as the primary treatment modality for small HCC because its overall survival rate is comparable to that of liver transplantation.
Moreover, because salvage liver transplantation produces attractive results, liver resection, including minor and non-anatomical resection, can be chosen as a primary treatment option for patients with small HCC, even for those with risk factors of a poor prognosis.
